http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2374895-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a596c843ab694a8cac853d90d6dadc8f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B63-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B63-00
filingDate 2008-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689334aadf263650c1239da8e2498a66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db557d5d4f110831b221758619d55d47
publicationDate 2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2374895-T3
titleOfInvention PURIFICATION PROCEDURE FOR THE PREPARATION OF THE 3'-DESOXI-3 'RADIOACTIVE TRAVELER - [18F] -FLUORTIMIDINE ([18F] FLT).
abstract Method for the preparation of the radioactive tracer 3'-Deoxy-3 '- [18 F] fluortimidine ([18 F] FLT), comprising the following steps: a) Preparation of [18 F] F-fluoride anhydrous; b) Marking of a precursor, for example 3-N-Boc-1- [5'-O- (4,4'-dimethoxytrityl) -3'-O-nitrophenylsulfonyl-2'deoxy-β-D-lixofuranosyl] thymidine ; c) Hydrolysis of the mixture obtained through the previous phases; d) Purification of the mixture to obtain the radioactive tracer [18 F] FLT, in which phases a), b) and c) are carried out by means of known procedures, the procedure being characterized in that the mixture obtained after the phase c) is purified by passing through a vented filter and one or more cartridges of the cation exchange rate (for example, a Cromafix PS-H +), one or more cartridges of the reverse phase type, and finally a passage through either alumina N type cartridges, or diol cartridges, or anion exchange cartridges or a combination thereof, and because the mixture with that presented in the cartridges is diluted with H2O for injection, whereby the resulting product is sent to a container or blister for the collection of [18 F] FLT.
priorityDate 2007-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410440376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148241732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9878109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426405906

Total number of triples: 31.